|
"余忠仁"的相關文件
顯示項目 116-125 / 388 (共39頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2015 |
Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria
|
Chien, Jung-Yien; Chang, Tsung-Chain; Chiu, Wei-Yih; Yu, Chong-Jen; Hsueh, Po-Ren; 薛博仁; 余忠仁; 邱偉益; 簡榮彥 |
| 國立臺灣大學 |
2015 |
Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.
|
Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 余忠仁; 何肇基; 施金元; 李日翔 |
| 國立臺灣大學 |
2015 |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang, James C-H; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long; 楊志新; 余忠仁 |
| 國立臺灣大學 |
2015 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao, Bin-Chi; Lee, Jih-Hsiang; Lin, Chia-Chi; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 陳雅芳; 余忠仁; 何肇基; 施金元; 李日翔; 張晉豪 |
| 國立臺灣大學 |
2015 |
EGFR Mutation Status Is Associated With Better Radiographic Response and Predicts Favorable Outcomes in Non-Small Cell Lung Cancer Patients With Brain Metastases Treated by Stereotactic Radiosurgery
|
Yang, W. C.; Xiao, F. R.; Shih, J. Y.; Ho, C. C.; Chen, Y. F.; Tseng, H. M.; Chen, K. Y.; Liao, W. Y.; Yu, C. J.; Yang, J. C. H.; Kuo, S. H.; Cheng, J. C. H.; Yang, P. C.; Hsu, F. M.; 曾漢民; 陳雅芳; 楊泮池; 廖唯昱; 郭頌鑫; 陳冠宇; 余忠仁; 成佳憲; 何肇基; 蕭輔仁; 施金元; 許?銘 |
| 國立臺灣大學 |
2014 |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chang, Gee-Chen; 俞松良; 蘇剛毅; 廖唯昱; 余忠仁 |
| 國立臺灣大學 |
2014 |
Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元 |
| 國立臺灣大學 |
2014 |
Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010
|
Chen, Pao-Yu; Chuang, Yu-Chung; Wang, Jann-Tay; Sheng, Wang-Huei; Yu, Chung-Jen; Chu, Chen-Chen; Hsueh, Po-Ren; Chang, Shan-Chwen; Chen, Yee-Chun; 張上淳; 朱蓁蓁; 薛博仁; 余忠仁; 陳宜君; 盛望徽; 王振泰; 莊祐中 |
| 國立臺灣大學 |
2014 |
Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non-Small-Cell Lung Cancer
|
Wang, Cheng-Yi; Chao, Ting-Ting; Tai, Wei-Tien; Chang, Fang-Yu; Su, Wen-Pin; Chen, Yen-Lin; Chen, Pao-Tzu; Weng, Ching-Yu; Yuan, Ang; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 袁昂; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation
|
Wang, Cheng-Yi; Chao, Ting-Ting; Chang, Fang-Yu; Chen, Yen-Lin; Tsai, Yi-Ting; Lin, Hen-I; Huang, Yuh-Chin T.; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
顯示項目 116-125 / 388 (共39頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目
|
